An international research group led by the Helmholtz Center for Infection Research (HZI) has discovered a promising new drug ...
Eli Lilly sues two compounders over tirzepatide after FDA lifts Zepbound, Mounjaro shortage status in key GLP-1 legal test.
A precision medicine workflow integrating proteomics and personalized xenograft models was developed and applied to an ...
Cotemporary DES paired with FFR guidance and modern medical therapy may be what narrowed the gap, William Fearon says.
The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by ...
This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.
Patients with aortic stenosis were excluded from earlier trials of the SGLT2 inhibitor, but new data confirm they too can ...
TNF inhibitor use demonstrates no negative impact on survival among patients recently diagnosed with colorectal, lung or ...
sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved ... and the angiotensin II subtype 1 receptor (AT 1 R). It is currently approved to slow ...
sNDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved ... and the angiotensin II subtype 1 receptor (AT 1 R). It is currently approved to slow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback